Menu

Featured News

Some of the leading stories and synthetic biology information from SynbiCITE

Engineering Biology: the new IET open access journal

​The Institution of Engineering and Technology (IET) has launched a new journal, entitled Engineering Biology, to reflect the fact that synthetic biology/engineering biology is, fundamentally, now widely recognised as a field of engineering.

Read article

Shooting for the moon: SynbiCITE share industrial knowledge at GP-write

On May 9th and 10th, 2017 around 250 scientists, industry leaders, policy makers and ethicists gathered at the New York Genome Center for the second meeting of GP-write. GP-write is an open, international collaboration that aims to reduce by 1,000-fold within 10 years the costs of engineering and testing large genomes in cell lines. Dr David McClymont, Head of Automation, The London DNA Foundry, shares his thoughts. 

Read article

UK Engineering Biology Market Report 2017

The UK’s first report on the Engineering Biology industry following a year of significant progress in the sector.

SynbiCITE’s UK Engineering Biology Market Report 2017 will assess the current and potential size of the Engineering Biology industry, looking closely at growth trends, company scale, the value of the sector, key stakeholders and the commercial impact it could have.The challenges facing the industry, such as funding and IP protection, regulatory issues and ethics will also be evaluated. The completed report will be available Spring 2017.

Register for your complimentary electronic copy

Innovation, education & collaboration

Watch SynbiCITE's new film to get an insight into the potential that synthetic biology offers us all.

Synthetic biology is unlocking significant new opportunities for industries ranging from life sciences and specialty chemicals to bioenergy and waste remediation. By facilitating the creation of new tools and techniques, synbio has the potential to reshape many technologies to affect our lives positively and to reduce the impact that we have on our planet. Synbio is the engineering of biology and it’s already helping to make many businesses more effective, more productive and more environmentally friendly.

SynbiCITE has created a globally renowned national resource of interacting partners from academia, industry and business across the UK which accelerates the commercialisation of world-class science and the emerging technologies encompassed by synthetic biology and engineering biology into new products, tools, processes and services.

Discover more

Resources

SynbiCITE has a number of resources available to all our partners to use for the translation of their research into new products, tools and processes.

View our resources

We partner with some of the world’s most forward-thinking organisations

We support our partners through events and training programmes including problems-solutions brokerage meetings. We provide funding of development projects including seed funding of Proof of Concept projects and follow-on funding of longer, larger projects for the development of prototypes and taking these on to pilot production scale manufacturing.

View our network

Synthetic Biology community

Take a look at the active and interactive synthetic biology community. Join the conversation and get involved.
Engineering Biology Showcase

6 June 2017

View event
Engineering Biology: the new IET open access journal

​The Institution of Engineering and Technology (IET) has launched a new journal, entitled Engineering Biology, to reflect the fact that synthetic biology/engineering biology is, fundamentally, now widely recognised as a field of engineering.

Read blog article
Stephen Chambers

@spchambers007

  • 1
  • 3
Stephen Chambers

@spchambers007

  • 2
  • 4
Shooting for the moon: SynbiCITE share industrial knowledge at GP-write

On May 9th and 10th, 2017 around 250 scientists, industry leaders, policy makers and ethicists gathered at the New York Genome Center for the second meeting of GP-write. GP-write is an open, international collaboration that aims to reduce by 1,000-fold within 10 years the costs of engineering and testing large genomes in cell lines. Dr David McClymont, Head of Automation, The London DNA Foundry, shares his thoughts. 

Read blog article
SynbiCITE

@SynbiCITE

  • 3
  • 3
Stephen Chambers

@spchambers007

  • 3
  • 2
Synpromics raises £5.2m of new investment

Synpromics Ltd, the leading synthetic promoter and gene control company, is pleased to announce that it has completed a financing round of £5.2M. Participants included existing investors Calculus Capital, the Scottish Investment Bank, the investment arm of Scottish Enterprise and private shareholders.

Read article
SynbiCITE

@SynbiCITE

  • 0
  • 2
SynbiCITE

@SynbiCITE

  • 13
  • 11
Touchlight welcomes Dr. Geoff Smith

Touchlight is very pleased to welcome Dr. Geoff Smith as the Head of Innovations. Geoff brings extensive experience in genomics technologies and applications, with roles including Vice President leading Technology Development at Illumina and CEO of Cambridge Epigenetix.

Read article
Japanese government delegation seeks SynbiCITE’s advice on start-ups creation and synthetic biology business opportunities

A recent UK visit by a high-level Japanese delegation of government officials and industrialists recognises the tremendous progress the UK has made, building on its established lead in Europe, towards becoming a major global biotech cluster.

Read blog article